Breast cancer cells shifted into HER2 positive status with bold new strategy

(Scripps Research Institute) One of the most effective breast cancer drugs, Herceptin, is only available to people whose tumors test HER2-positive. That's only one in five breast cancer patients. That could change with a new approach from Scripps Research.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news